You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Acute promyelocytic leukemia (APL) refractory to arsenic therapy or retinoic acid therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

APL Trial in Shanghai (Chidamide+venetoclax)

Active, not recruiting
  • APL
  • Shanghai, Shanghai, China
    Jiong HU
May 30, 2023

Acute Promyelocytic Leukemia, Induction Therapy, Oral Trial in Beijing (Etoposide, Daunorubicin)

Recruiting
  • Acute Promyelocytic Leukemia
  • +2 more
  • Beijing, Beijing, China
    Peking University Institute of Hematology
Apr 26, 2023

Promyelocytic Leukemia Trial in Monterrey (Arsenic trioxide, all-trans retinoic acid)

Recruiting
  • Promyelocytic Leukemia
  • Arsenic trioxide
  • all-trans retinoic acid
  • Monterrey, Nuevo Leon, Mexico
    Hopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Aug 9, 2022

RWE of 1st Line Treatment With ATO/ATRA for Adult APL

Recruiting
  • Promyelocytic Leukemia, Adult Acute
  • Evaluation of first line treatment with ATO/ATRA outcome
  • Caba, Argentina
  • +1 more
Nov 9, 2021

Newly-diagnosed APL (de Novo or Therapy-related), Relapsed APL Trial in Dresden (observational)

Recruiting
  • Newly-diagnosed APL (de Novo or Therapy-related)
  • Relapsed APL
  • observational
  • Dresden, Germany
    Prof. Dr. U. Platzbecker
Aug 10, 2022

Acute Promyelocytic Leukemia Trial in Xi'an (Realgar-Indigo naturalis formula, all-trans retinoic acid, Arsenic trioxide)

Recruiting
  • Acute Promyelocytic Leukemia
  • Realgar-Indigo naturalis formula
  • +3 more
  • Xi'an, Shaanxi, China
    First Affiliated Hospital of Xi'an Jiaotong University
Aug 31, 2021

Acute Promyelocytic Leukemia Trial in Canada, United States (Tretinoin and Arsenic Trioxide)

Completed
Has Results
  • Acute Promyelocytic Leukemia
  • Tretinoin and Arsenic Trioxide
  • Los Angeles, California
  • +11 more
Nov 2, 2021

Leukemia Trial in Tianjin (DNR:, Ara-c)

Completed
Has Results
  • Leukemia
  • Tianjin, Tianjin, China
  • +1 more
Aug 8, 2021

Acute Promyelocytic Leukemia Trial in Worldwide (Mylotarg, Arsenic Trioxide, All-trans retinoic acid)

Recruiting
  • Acute Promyelocytic Leukemia
  • Brussels, Belgium
  • +30 more
Aug 9, 2022

MDS, de Novo, MDS, Secondary, MDS, Previously Treated Trial in Boston (Venetoclax, Azacitidine, Cytarabine)

Recruiting
  • Myelodysplastic Syndromes, de Novo
  • +10 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 23, 2023

Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,

Completed
  • Acute Myelogenous Leukemia
  • +2 more
  • New York, New York
    Columbia University Medical Center
Aug 4, 2021

Leukemia Trial in Austria, Germany, Italy (arsenic trioxide, idarubicin, mercaptopurine)

Completed
  • Leukemia
  • arsenic trioxide
  • +5 more
  • Innsbruck, Austria
  • +109 more
Oct 10, 2022

Leukemia Trial in Chicago, Kankakee (recombinant interferon alfa, amifostine trihydrate, bromodeoxyuridine)

Withdrawn
  • Leukemia
  • recombinant interferon alfa
  • +7 more
  • Chicago, Illinois
  • +3 more
Oct 6, 2021

The Acute Promyelocytic Leukaemia Asian Consortium Project

Recruiting
  • Acute Promyelocytic Leukemia
    • Hong Kong, Hong Kong
      Department of Medicine, the University of Hong Kong, Queen Mary
    Oct 3, 2022

    Refractory Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome Trial in Houston (Fostamatinib)

    Recruiting
    • Refractory Chronic Myelomonocytic Leukemia
    • Refractory Myelodysplastic Syndrome
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 31, 2021

    Childhood Acute Promyelocytic Leukemia (M3), Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Trial in

    Active, not recruiting
    Has Results
    • Childhood Acute Promyelocytic Leukemia (M3)
    • Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    • arsenic trioxide
    • +7 more
    • Birmingham, Alabama
    • +110 more
    Mar 23, 2022

    Acute Promyelocytic Leukaemia Trial (Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid)

    Not yet recruiting
    • Acute Promyelocytic Leukaemia
    • Compound Realgar-Indigo Naturalis Formula Plus Retinoic Acid
    • (no location specified)
    Nov 26, 2019

    AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed

    Recruiting
    • AML According to WHO 2016 Classification (Except Acute Promyelocytic Leukemia) AND (Refractory to Induction Therapy OR Relapsed After First Line Treatment)
    • MRD-triggered arm
    • Prophylactic Arm
    • Heidelberg, BW, Germany
      University Hospital Heidelberg Med5
    Jan 4, 2021

    Arsenic Trioxide in Newly Diagnosed, Low-to-intermediate Risk

    Recruiting
    • Acute Promyelocytic Leukemia
    • Arsenic Trioxide
    • Alessandria, Italy
    • +27 more
    Dec 31, 2021

    Acute Myeloid Leukemia Trial in Xi'an (All-trans retinoic acid, Arsenic Trioxide, Realgar-Indigo naturalis formula)

    Recruiting
    • Acute Myeloid Leukemia
    • All-trans retinoic acid
    • +2 more
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Mar 23, 2022

    Solid Tumor, Adult Trial in Shanghai, Hangzhou (HF1K16 /Arm 45 mg/m2, HF1K16 /Arm 90 mg/m2, HF1K16 /Arm 120 mg/m2)

    Recruiting
    • Solid Tumor, Adult
    • HF1K16 /Arm 45 mg/m2
    • +3 more
    • Shanghai, Shanghai, China
    • +2 more
    May 23, 2022

    Acute Promyelocytic Leukemia Trial in Shanghai (ATRA+Arsenic, ATRA+Chemo)

    Unknown status
    • Acute Promyelocytic Leukemia
    • Shanghai, China
      Department of Hematology
    Aug 15, 2019

    Leukemia Trial in United States (arsenic trioxide, gemtuzumab ozogamicin, mercaptopurine)

    Completed
    Has Results
    • Leukemia
    • arsenic trioxide
    • +4 more
    • Roseville, California
    • +191 more
    Dec 14, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

    Active, not recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia
    • +125 more
    • tetanus-CMV fusion peptide vaccine
    • laboratory biomarker analysis
    • Duarte, California
      City of Hope Medical Center
    Feb 28, 2022

    Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

    Completed
    Has Results
    • Leukemia
    • Scottsdale, Arizona
    • +209 more
    Dec 14, 2022